Search

Search Results

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  1825

  PDF: 564

  HTML: 15
• 

  Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

  Chuyen Thi Hong Nguyen, Oanh Phan Tram Nguyen

  21-11-2022

  1044

  PDF: 385

  HTML: 22
• 

  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

  Hao Trong Nguyen, Long Dinh Hoang Vo, Nguyen Nhat Pham

  14-07-2022

  1248

  PDF: 487

  HTML: 9

• Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

  Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

  11-09-2023

  584

  PDF: 324

  HTML: 8
• 

  Certolizumab to treat hidradenitis suppurativa

  Asem Shadid, Saud Alobaida, Yousef Binamer

  27-10-2022

  1449

  PDF: 530

  HTML: 20
• 

  Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study

  Tannaz Dehpouri, Ghasem Rahmatpour Rokni, Nematollah Ahangar Narenjbon, Mohamad Goldust, Paul S. Yamauchi, Uwe Wollina, Torello Lotti, Leon Kircik, Vito Giuseppe Di Lernia, Sidharth Sonthalia, Aleksandra Vojvodic, Jacek Szepietowski, Philippe Bahadoran, Enzo Errichetti, Carmen Cantisani, Laura Atzori, Elham Rezaee, Zekayi Kutlubay, Burhan Engin, Steven Nisticò, Giovanni Damiani, Rosalynn R.Z. Conic, Andy Goren, Leo Čabrijan, Georgi Tchernev

  09-05-2019

  1821

  PDF: 766

  HTML: 885
• 

  Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

  Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

  29-12-2022

  1474

  PDF: 360

  HTML: 58
• 

  Erythrodermic psoriasis treated with apremilast

  John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

  19-09-2016

  1831

  PDF: 816

  HTML: 595

• HLA-Cw6 increases the risk of psoriasis and early onset before twenty-seven years of age among the Vietnamese population

  Nhi Thi Uyen Pham, Thuong Van Nguyen, Hao Trong Nguyen

  16-10-2023

  736

  PDF: 300

  HTML: 13
• 

  Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

  Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  19-05-2023

  724

  PDF: 367

  HTML: 12
• 

  Two episodes of cutaneous non-tuberculous mycobacterial infection in a patient with psoriasis

  Wai Sze Agnes Chan, Shang-Ian Tee, Nisha Su Yien Chandran, Jiun Yit Pan

  15-06-2015

  1721

  PDF: 698

  HTML: 771
• 

  Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

  Federica Mola, Alberico Motolese

  e40

  03-10-2011

  1109

  PDF: 503

  HTML: 1028
• 

  Four-years experience with the preferential derivation care model for multidisciplinary care in patients with psoriasis and psoriatic arthritis

  Martina Burlando, Chiara Craviotto, Luca Carmisciano , Gerolamo Bianchi, Aurora Parodi

  08-10-2021

  644

  PDF: 307

  HTML: 2
• 

  Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

  Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

  21-11-2022

  1300

  PDF: 306

  HTML: 16